EE200300003A - Perindopriili tert-butüülamiinsoola kristallilinekamma-vorm, selle valmistamise protsess ning sedasisaldavad farmatseutilised kompositsioonid - Google Patents

Perindopriili tert-butüülamiinsoola kristallilinekamma-vorm, selle valmistamise protsess ning sedasisaldavad farmatseutilised kompositsioonid

Info

Publication number: EE200300003A
Authority: EE; Estonia
Prior art keywords: lingam; crystalline; preparation; pharmaceutical compositions; compositions containing
Prior art date: 2000-07-06

Application number

EEP200300003A

Other languages

English (en)

Inventor

Pfeiffer Bruno

Ginot Yves-Michel

Coquerel G�rard

Beilles St�phane

Original Assignee

Les Laboratoires Servier

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-07-06

Filing date

2001-07-06

Publication date

2004-08-16

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8852170&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EE200300003(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2001-07-06 Application filed by Les Laboratoires Servier filed Critical Les Laboratoires Servier

2004-08-16 Publication of EE200300003A publication Critical patent/EE200300003A/et

2010-04-15 Publication of EE05286B1 publication Critical patent/EE05286B1/et

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Urology & Nephrology (AREA)
Hospice & Palliative Care (AREA)
Vascular Medicine (AREA)
Diabetes (AREA)
Hematology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Indole Compounds (AREA)

EEP200300003A 2000-07-06 2001-07-06 Perindopriili tert-butlamiinsoola kristalliline kamma-vorm, protsess selle valmistamiseks ning seda sisaldavad farmatseutilised kompositsioonid EE05286B1 (et)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
FR0008791A FR2811318B1 (fr)	2000-07-06	2000-07-06	Nouvelle forme cristalline gamma du sel de tert-butylamine du perindopril, son procede de preparation et les compositions pharmaceutiques qui la contiennent
PCT/FR2001/002169 WO2001083439A2 (fr)	2000-07-06	2001-07-06	NOUVELLE FORME CRISTALLINE η DU SEL DE TERT-BUTYLAMINE DU PERINDOPRIL, SON PROCEDE DE PREPARATION, ET LES COMPOSITIONS PHARMACEUTIQUES QUI LA CONTIENNENT

Publications (2)

Publication Number	Publication Date
EE200300003A true EE200300003A (et)	2004-08-16
EE05286B1 EE05286B1 (et)	2010-04-15

Family

ID=8852170

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EEP200300003A EE05286B1 (et)	2000-07-06	2001-07-06	Perindopriili tert-butlamiinsoola kristalliline kamma-vorm, protsess selle valmistamiseks ning seda sisaldavad farmatseutilised kompositsioonid

Country Status (35)

Country	Link
US (2)	US20030158121A1 (et)
EP (1)	EP1296948B1 (et)
JP (2)	JP3592296B2 (et)
KR (1)	KR100513572B1 (et)
CN (1)	CN1328258C (et)
AP (1)	AP1452A (et)
AR (1)	AR029570A1 (et)
AT (1)	ATE249435T1 (et)
AU (2)	AU7642001A (et)
BG (1)	BG66239B1 (et)
BR (1)	BR0112211A (et)
CA (1)	CA2415447C (et)
CZ (1)	CZ302022B6 (et)
DE (1)	DE60100761T2 (et)
DK (1)	DK1296948T3 (et)
EA (1)	EA004275B1 (et)
EE (1)	EE05286B1 (et)
ES (1)	ES2206423T3 (et)
FR (1)	FR2811318B1 (et)
GE (1)	GEP20043362B (et)
HR (1)	HRP20030078B1 (et)
HU (1)	HU228115B1 (et)
ME (1)	ME01367B (et)
MX (1)	MXPA02012904A (et)
NO (1)	NO323445B1 (et)
NZ (1)	NZ523311A (et)
OA (1)	OA12306A (et)
PL (1)	PL348491A1 (et)
PT (1)	PT1296948E (et)
RS (1)	RS51621B (et)
SI (1)	SI1296948T1 (et)
SK (1)	SK287452B6 (et)
UA (1)	UA57187C2 (et)
WO (1)	WO2001083439A2 (et)
ZA (1)	ZA200300025B (et)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2811320B1 (fr) *	2000-07-06	2002-08-23	Adir	Nouvelle forme cristalline alpha du sel de tert-butylamine du perindopril, son procede de preparation et les compositions pharmaceutiques qui la contiennent
FR2811319B1 (fr)	2000-07-06	2002-08-23	Adir	Nouvelle forme cristalline beta du sel de tert-butylamine du perindopril, son procede de preparation et les compositions pharmaceutiques qui la contiennent
FR2834893B1 (fr) *	2002-01-23	2004-02-27	Servier Lab	Composition pharmaceutique orodispersible de perindopril
GB2395195A (en) *	2002-11-18	2004-05-19	Cipla Ltd	Preparation of perindopril from carboxy-protected precursor, & perindopril monohydrates for use as angiotensin converting enzyme (ACE) inhibitors
ATE540924T1 (de) *	2003-06-24	2012-01-15	Servier Lab	Neue kristalline formen von perindopril erbumine
AU2003263584A1 (en) *	2003-08-21	2005-03-10	Hetero Drugs Limited	Process for pure perindopril tert-butylamine salt
AU2003300689B2 (en)	2003-10-21	2009-01-29	Les Laboratoires Servier	Novel method for preparation of crystalline perindopril erbumine
SI21703A (en)	2004-01-14	2005-08-31	Lek Farmacevtska Druzba Dd	Inclusion complexes of perindopril, procedure of their preparation, pharmaceutical compositions containing these complexes and their application in treatment of hypertensia
SI21704A (en) *	2004-01-14	2005-08-31	Lek Farmacevtska Druzba Dd	New crystal form of perindopril, procedure of its preparation, pharmaceutical preparations containing this form and their application in treatment of hypertensia
HRP20161602T1 (hr) *	2004-03-29	2016-12-30	Les Laboratoires Servier	Postupak priprave čvrstog farmaceutskog pripravka
SI21800A (sl)	2004-05-14	2005-12-31	Krka, Tovarna Zdravil, D.D., Novo Mesto	Nov postopek sinteze perindoprila
SI21881A (sl)	2004-10-15	2006-04-30	Diagen, Smartno Pri Ljubljani, D.O.O.	Nove kristalne oblike perindopril erbumin hidratov, postopek za njihovo pripravo in farmacevtske oblike, ki vsebujejo te spojine
SG125975A1 (en) *	2005-03-11	2006-10-30	Servier Lab	New alpha crystalline form of perindopril tert-butylamine salt, a process for its preparation and pharmaceutical compositions containing it
SG125976A1 (en) *	2005-03-11	2006-10-30	Servier Lab	New gama crystalline form of perindopril tert-butylamine salt, a process for its preparation and pharmaceutical compositions containing it
JP2006290825A (ja) *	2005-04-13	2006-10-26	Shiono Chemical Co Ltd	アルファ型ペリンドプリルエルブミンの製造法
WO2007017894A2 (en) *	2005-05-05	2007-02-15	Arch Pharmalabs Limited	PREPARATION OF NOVEL CRYSTALLINE η(ETA) FORM OF PERINDOPRIL ERBUMINE
CA2618561C (en) *	2005-08-12	2014-04-29	Lek Pharmaceuticals D.D.	A process for the preparation of perindopril erbumine
US20090099370A1 (en) *	2005-08-12	2009-04-16	Sandoz Ag	Crystalline Form of Perindopril Erbumine
EP1815857A1 (en)	2006-02-02	2007-08-08	LEK Pharmaceuticals D.D.	A pharmaceutical composition comprising perindopril
WO2007092758A2 (en) *	2006-02-03	2007-08-16	Dr. Reddy's Laboratories Ltd.	Crystalline forms of perindopril erbumine
FR2897866B1 (fr) *	2006-02-28	2008-04-18	Servier Lab	Forme cristalline alpha du sel d'arginine du perindopril, son procede de preparation, et les compositions pharmaceutiques qui la contiennent
FR2897865B1 (fr)	2006-02-28	2008-04-18	Servier Lab	Forme cristalline beta du sel d'arginine du perindopril, son procede de preparation, et les compositions pharmaceutiques qui la contiennent
WO2008114270A1 (en) *	2007-03-22	2008-09-25	Aarti Healthcare Limited	Process for the preparation of perindopril erbumine salt and novel polymorph (s) thereof
WO2008120241A2 (en) *	2007-03-29	2008-10-09	Ipca Laboratories Limited	Novel alcohol solvates of perindopril erbumine
SI22543A (sl) *	2007-06-27	2008-12-31	Krka, Tovarna Zdravil, D.D., Novo Mesto	Nove soli perindoprila
PL2318365T3 (pl) *	2008-06-24	2016-02-29	Mylan Laboratories Ltd	Nowe odmiany polimorficzne (L) argininianu peryndoprylu i sposoby ich wytwarzania
KR200453510Y1 (ko) *	2009-02-09	2011-05-11	윤유원	튀김유 정제기
KR101041878B1 (ko) *	2009-03-26	2011-06-15	신준호	튀김장치용 찌꺼기 제거장치
SI23149A (sl)	2009-09-21	2011-03-31	Silverstone Pharma	Nove benzatinske soli ACE inhibitorjev, postopek za njihovo pripravo in njihova uporaba za zdravljenje kardiovaskularnih bolezni
PT105315B (pt)	2010-09-29	2013-01-16	Inst Superior Tecnico	Uma nova forma cristalina hidratada de erbumina de perindopril, métodos para a sua preparação e sua utilização em preparações farmacêuticas
EP3842035A1 (en)	2019-12-23	2021-06-30	KRKA, d.d., Novo mesto	Composition for the preparation of perindopril arginine granules, a method for their preparation and pharmaceutical composition comprising the granules

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2503155A2 (fr) *	1980-10-02	1982-10-08	Science Union & Cie	Nouveaux imino diacides substitues, leurs procedes de preparation et leur emploi comme inhibiteur d'enzyme
FR2620703B1 (fr) *	1987-09-17	1991-10-04	Adir	Procede de synthese industrielle de l'acide perhydroindole carboxylique - 2(2s, 3as, 7as). application a la synthese de carboxyalkyl dipeptides
FR2620709B1 (fr) *	1987-09-17	1990-09-07	Adir	Procede de synthese industrielle du perindopril et de ses principaux intermediaires de synthese
FR2771010B1 (fr) *	1997-11-19	2003-08-15	Adir	Utilisation d'une combinaison d'un inhibiteur de l'enzyme de conversion de l'angiotensine et d'un diuretique pour le traitement des desordres microcirculatoires
FR2811320B1 (fr) *	2000-07-06	2002-08-23	Adir	Nouvelle forme cristalline alpha du sel de tert-butylamine du perindopril, son procede de preparation et les compositions pharmaceutiques qui la contiennent
FR2811319B1 (fr) *	2000-07-06	2002-08-23	Adir	Nouvelle forme cristalline beta du sel de tert-butylamine du perindopril, son procede de preparation et les compositions pharmaceutiques qui la contiennent

2000
- 2000-07-06 FR FR0008791A patent/FR2811318B1/fr not_active Expired - Fee Related
2001
- 2001-06-07 UA UA2003021019A patent/UA57187C2/uk unknown
- 2001-07-05 HU HU0102814A patent/HU228115B1/hu not_active IP Right Cessation
- 2001-07-06 GE GE5074A patent/GEP20043362B/en unknown
- 2001-07-06 US US10/312,903 patent/US20030158121A1/en not_active Abandoned
- 2001-07-06 BR BR0112211-8A patent/BR0112211A/pt not_active Application Discontinuation
- 2001-07-06 JP JP2001580868A patent/JP3592296B2/ja not_active Expired - Fee Related
- 2001-07-06 PL PL01348491A patent/PL348491A1/xx not_active Application Discontinuation
- 2001-07-06 CN CNB018123538A patent/CN1328258C/zh not_active Expired - Fee Related
- 2001-07-06 EA EA200300104A patent/EA004275B1/ru not_active IP Right Cessation
- 2001-07-06 EE EEP200300003A patent/EE05286B1/et not_active IP Right Cessation
- 2001-07-06 DE DE60100761T patent/DE60100761T2/de not_active Expired - Lifetime
- 2001-07-06 RS YU100302A patent/RS51621B/sr unknown
- 2001-07-06 ES ES01954060T patent/ES2206423T3/es not_active Expired - Lifetime
- 2001-07-06 SK SK150-2003A patent/SK287452B6/sk not_active IP Right Cessation
- 2001-07-06 PT PT01954060T patent/PT1296948E/pt unknown
- 2001-07-06 WO PCT/FR2001/002169 patent/WO2001083439A2/fr not_active Ceased
- 2001-07-06 AU AU7642001A patent/AU7642001A/xx active Pending
- 2001-07-06 AR ARP010103224A patent/AR029570A1/es not_active Application Discontinuation
- 2001-07-06 KR KR10-2003-7000117A patent/KR100513572B1/ko not_active Expired - Fee Related
- 2001-07-06 MX MXPA02012904A patent/MXPA02012904A/es active IP Right Grant
- 2001-07-06 OA OA1200200399A patent/OA12306A/en unknown
- 2001-07-06 HR HR20030078A patent/HRP20030078B1/xx not_active IP Right Cessation
- 2001-07-06 EP EP01954060A patent/EP1296948B1/fr not_active Expired - Lifetime
- 2001-07-06 NZ NZ523311A patent/NZ523311A/en not_active IP Right Cessation
- 2001-07-06 SI SI200130029T patent/SI1296948T1/xx unknown
- 2001-07-06 AU AU2001276420A patent/AU2001276420B2/en not_active Ceased
- 2001-07-06 DK DK01954060T patent/DK1296948T3/da active
- 2001-07-06 ME MEP-2008-672A patent/ME01367B/me unknown
- 2001-07-06 AP APAP/P/2002/002709A patent/AP1452A/en active
- 2001-07-06 CZ CZ20030358A patent/CZ302022B6/cs not_active IP Right Cessation
- 2001-07-06 AT AT01954060T patent/ATE249435T1/de active
- 2001-07-06 CA CA002415447A patent/CA2415447C/fr not_active Expired - Fee Related
2003
- 2003-01-02 ZA ZA200300025A patent/ZA200300025B/en unknown
- 2003-01-06 NO NO20030051A patent/NO323445B1/no not_active IP Right Cessation
- 2003-02-05 BG BG107534A patent/BG66239B1/bg unknown
2004
- 2004-03-29 US US10/811,727 patent/US20040248817A1/en not_active Abandoned
- 2004-07-13 JP JP2004206157A patent/JP5016184B2/ja not_active Expired - Fee Related

Also Published As

Publication number	Publication date
ES2206423T3 (es)	2004-05-16
BG66239B1 (bg)	2012-08-31
HK1058199A1 (en)	2004-05-07
JP2005002120A (ja)	2005-01-06
EP1296948A2 (fr)	2003-04-02
HRP20030078B1 (en)	2004-06-30
ZA200300025B (en)	2004-02-10
PT1296948E (pt)	2003-12-31
JP3592296B2 (ja)	2004-11-24
NO20030051L (no)	2003-01-06
FR2811318B1 (fr)	2002-08-23
GEP20043362B (en)	2004-06-10
UA57187C2 (uk)	2003-06-16
MXPA02012904A (es)	2003-09-22
HU228115B1 (hu)	2012-11-28
US20030158121A1 (en)	2003-08-21
CZ302022B6 (cs)	2010-09-08
CA2415447C (fr)	2008-12-09
EP1296948B1 (fr)	2003-09-10
HRP20030078A2 (en)	2003-04-30
AP1452A (en)	2005-07-11
NZ523311A (en)	2004-06-25
SK1502003A3 (en)	2003-06-03
OA12306A (en)	2003-12-23
AR029570A1 (es)	2003-07-02
HUP0102814A3 (en)	2003-12-29
NO323445B1 (no)	2007-05-07
WO2001083439A2 (fr)	2001-11-08
JP2003531890A (ja)	2003-10-28
SK287452B6 (sk)	2010-10-07
CN1440386A (zh)	2003-09-03
AU7642001A (en)	2001-11-12
ME01367B (me)	2013-12-20
FR2811318A1 (fr)	2002-01-11
EA004275B1 (ru)	2004-02-26
ATE249435T1 (de)	2003-09-15
BG107534A (bg)	2003-12-31
CA2415447A1 (fr)	2001-11-08
CZ2003358A3 (cs)	2003-05-14
US20040248817A1 (en)	2004-12-09
BR0112211A (pt)	2003-05-06
PL348491A1 (en)	2002-01-14
KR100513572B1 (ko)	2005-09-09
HUP0102814A2 (hu)	2002-02-28
RS51621B (sr)	2011-08-31
AU2001276420B2 (en)	2006-11-16
WO2001083439A3 (fr)	2002-02-07
CN1328258C (zh)	2007-07-25
JP5016184B2 (ja)	2012-09-05
KR20030024774A (ko)	2003-03-26
EE05286B1 (et)	2010-04-15
DE60100761D1 (de)	2003-10-16
NO20030051D0 (no)	2003-01-06
YU100302A (sh)	2003-08-29
HU0102814D0 (en)	2001-09-28
DE60100761T2 (de)	2004-07-15
AP2002002709A0 (en)	2002-12-31
EA200300104A1 (ru)	2003-06-26
DK1296948T3 (da)	2004-01-05
SI1296948T1 (en)	2003-12-31

Publication	Publication Date	Title
EE200300003A (et)	2004-08-16	Perindopriili tert-butüülamiinsoola kristallilinekamma-vorm, selle valmistamise protsess ning sedasisaldavad farmatseutilised kompositsioonid
EE200300002A (et)	2004-08-16	Perindopriili tert-butüülamiinsoola uudne kristalliline ß-vorm, protsess selle valmistamiseks ja seda sisaldavad farmatseutilised kompositsioonid
EE05268B1 (et)	2010-02-15	Perindopriili tert-butlamiinsoola kristalliline alfa-vorm, selle valmistamisprotsess ja seda sisaldavad farmatseutilised kompositsioonid
AU2001276420A1 (en)	2002-01-31	Novel gamma crystalline form of perindopril tert-butylamine salt, preparation method, and pharmaceutical compositions containing same.
EE200200409A (et)	2003-12-15	1,3-dihüdro-2H-indool-2-ooni derivaadid, nende valmistamismeetod ja neid sisaldavad farmatseutilised kompositsioonid
AU2001276419A1 (en)	2002-02-14	Novel beta crystalline form of perindopril tert- butylamine salt, preparation method and pharmaceutical compositions containing same
HUP0302519A3 (en)	2008-10-28	Crystalline forms of atorvastatin, process for their preparation and pharmaceutical compositions containing them
HUP0400998A3 (en)	2009-01-28	Novel compounds of anti-inflammatory, immunomodulatory and anti-proliferatory effect, process for their preparation and pharmaceutical compositions containing them
HUP0102723A3 (en)	2002-11-28	New diphenylurea derivatives, process for their preparation and pharmaceutical compositions containing them
HUP0303156A3 (en)	2004-03-29	Substituted 2-phenylaminoimidazoline derivatives as ip antagonists, process for their preparation and pharmaceutical compositions containing them
HUP0204157A3 (en)	2005-04-28	1,3-dihydro-2h-indol-2-one derivatives, process for preparation of the compounds and pharmaceutical compositions containing the same
HUP0401141A3 (en)	2011-07-28	Crystalline forms of fluvastatin sodium, process for their preparation and pharmaceutical compositions containing them
HUP0401499A3 (en)	2007-05-02	Indole derivatives as cox ii inhibitors, process for their preparation and pharmaceutical compositions containing them
HUP0401747A3 (en)	2005-06-28	Piridazine derivatives of hydrazono-malonitriles, their use, process for preparation of the compounds and pharmaceutical compositions containing the compounds
NO20040278L (no)	2004-01-21	Fremgangsmate for fremstilling av perindopril
EE200300488A (et)	2003-12-15	Lipiiditaset alandava toimega bifenüülkarboksamiidühend, meetod selle valmistamiseks ning seda sisaldav ravimkompositsioon
HUP0300389A3 (en)	2004-08-30	Crystalline form ii of cabergoline, process for its preparation and pharmaceutical compositions containing it
HUP0303270A3 (en)	2007-03-28	Isoxazoline derivatives as anti-depressants, process for their preparation and pharmaceutical compositions containing them
HUP0303105A3 (en)	2005-05-30	Novel aminocyclohexane derivatives, process for their preparation, pharmaceutical compositions containing them and their use
HUP0400207A3 (en)	2008-03-28	Substituted 4-aminocyclohexanol derivatives, process for their preparation and pharmaceutical compositions containing them
HUP0402283A3 (en)	2009-07-28	Substituted 2-pyrrolidine-2-yl-1h-indole derivatives for the treatment of migraine, process for their preparation and pharmaceutical compositions containing them
HU0102815D0 (en)	2001-09-28	New alpha crystalline form of perindopril tert-butylamine salt, process for its preparation and pharmaceutical compositions containing it
EE200400007A (et)	2004-02-16	Fenüületanoolamiini kristallivorm, selle valmistamine ja seda sisaldavad farmatseutilised kompositsioonid
EE200200528A (et)	2004-04-15	2-fenüülpüran-4-ooni derivaat, meetod selle valmistamiseks, seda sisaldav farmatseutiline kompositsioon ning ühendi ja kompositsiooni raviotstarbeline kasutamine
HU1000441D0 (en)	2010-10-28	Substituted alkylpyridazone derivatives, process for their preparation and pharmaceutical compositions containing them

Legal Events

Date	Code	Title	Description
2011-02-15	KB4A	Valid patent at the end of a year	Effective date: 20101231
2020-05-15	MM4A	Lapsed by not paying the annual fees	Effective date: 20190706